MDCO - The Medicines Company - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

The Medicines Company's activity chart (see below) currently has 107 price targets and 83 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 90.41% of the time, taking 918.88 days on average.

Most recent stock forecast was given by GBOLA AMUSA from on 26-Nov-2019. First documented stock forecast 16-Oct-2012.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Mar-2016

$85

$90

6 years 11 months 27 days ago
(26-Nov-2019)

2/5 (40%)

$85 (0.00%)

1093

Buy Since 23-Jun-2015

$85

6 years 11 months 28 days ago
(25-Nov-2019)

7/8 (87.5%)

$85 (0.00%)

1488

Buy Since 06-Jun-2018

$85

$100

6 years 11 months 28 days ago
(25-Nov-2019)

2/6 (33.33%)

$85 (0.00%)

392

Buy Since 30-Nov-2017

$85

$68

6 years 11 months 28 days ago
(25-Nov-2019)

6/7 (85.71%)

$85 (0.00%)

349

Hold Since 20-Nov-2019

$59

$55

7 years 2 days ago
(20-Nov-2019)

10/10 (100%)

$59 (0.00%)

566

Show more analysts

Please expand the browser size to see the chart

What is MDCO (The Medicines Company) average time for price targets to be met?

On average it took 919 days for the stock forecasts to be reached, with an average price target met ratio of 90.41%.

Which analyst most recently updated their price target on MDCO (The Medicines Company)?

Gbola Amusa

Which analyst has the most public recommendations on MDCO (The Medicines Company)?

Gbola Amusa has 4 price targets and 3 ratings on MDCO

Which analyst is the currently most bullish on MDCO (The Medicines Company)?

Gbola Amusa with the highest potential upside of $0.1

Which analyst is the currently most reserved on MDCO (The Medicines Company)?

David Amsellem with the lowest potential downside of -$53.9
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?